Transcription of April 2012 - WHO
{{id}} {{{paragraph}}}
Example: bachelor of science
April 2012 - WHO
Hiv/aids ProgrammeUse of AntiretrovirAl DrUgs for treAting PregnAnt Women AnD Preventing Hiv infection in infAntsEXECUTivE sUMMaRYApril 2012 PRogRaMMaTiC UPdaTE1 EXECUTIVE SUMMARY Recent developments suggest that substantial clinical and programmatic advantages can come from adopting a single, universal regimen both to treat HIV-infected pregnant women and to prevent mother-to-child transmission of HIV. This streamlining should maximize PMTCT programme performance through better alignment and linkages with antiretroviral therapy (ART) programmes at every level of service delivery. One of WHO s two currently recommended PMTCT antiretroviral (ARV) programme options, Option B, takes this unified approach. Now a new, third option (Option B+) proposes further evolution not only providing the same triple ARV drugs to all HIV-infected pregnant women beginning in the antenatal clinic setting but also continuing this therapy for all of these women for life.
1 EXECUTIVE SUMMARY Recent developments suggest that substantial clinical and programmatic advantages can come from adopting a single, universal regimen …
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
CLINICAL GUIDELINES: PMTCT Prevention of Mother, PMTCT Guidelines, National consolidated guidelines for the prevention, National consolidated guidelines for the prevention of mother, Pmtct, National consolidated guidelines, Prevention of mother, Guidelines for the Clinical Management of HIV Infection, And AIDS Policy and Legislation, And AIDS Policy and Legislation: An Analysis, Common conditions associated with maternal mortality, South Africa Country Operational Plan 2016